Which has grown faster, BNTX or WST?

Over the past five years, WST grew revenue faster — BNTX at a 2.16% CAGR versus WST at 6.72%.

Does BNTX or WST pay a bigger dividend?

WST pays a dividend (0.25% yield) while BNTX does not currently pay one.

Is BNTX or WST more profitable?

WST runs the higher net margin — BNTX at -44.73% versus WST at 16.85%.

Which has been the better investment, BNTX or WST?

Over the past 5-year, WST delivered the higher annualized total return — BNTX at -16.66% versus WST at 17.45%. Past performance doesn't predict future results.

BioNTech SE (BNTX) vs West Pharmaceutical Services, Inc. (WST)

WST leads on 6 of 10 compared metrics.

A side-by-side comparison of BioNTech SE and West Pharmaceutical Services, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 27, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

West Pharmaceutical Services, Inc.

$24.79B

$350.85Healthcare

Total return — BNTX vs WST

growth of $100 · last 7y

BNTX +540.6%WST +149.4%BNTX compounded faster

BNTX WST

BNTX vs WST: by the numbers

•WST is the larger company ($24.79B vs $23.07B market cap).
•WST is profitable (16.85% net margin) while BNTX runs a net loss (-44.73%).
•WST grew revenue faster over the past five years (6.72% vs 2.16% CAGR).
•WST pays a dividend (0.25% yield) while BNTX does not currently pay one.

Which is better, BNTX or WST?

Metric tally: BNTX 4 · WST 6

It depends on what you're optimizing for:

GrowthWST(faster 5Y revenue CAGR)

QualityWST(higher ROIC)

Metrics side by side

Valuation

Metric	BNTX	WST
P/E ratio	—	46.84
Forward P/E	—	36.63
P/S ratio	7.02●	7.89
P/B ratio	1.07●	8.49
PEG ratio	—	33.99
EV / EBITDA	—	29.94
FCF yield	6.48%●	1.80%

Profitability

Metric	BNTX	WST
Gross margin	73.26%●	36.24%
Operating margin	-22.63%	20.67%●
Net margin	-44.73%	16.85%●
ROE	-6.79%	18.15%●
ROIC	-3.14%	13.62%●

Dividends

Metric	BNTX	WST
Dividend yield	—	0.25%
Payout ratio	—	12.88%

Growth (annualized)

Metric	BNTX	WST
Revenue CAGR (5Y)	2.16%	6.72%●
EPS CAGR (5Y)	—	7.85%
FCF CAGR (5Y)	—	8.32%
Total return CAGR (5Y)	-16.66%	-0.26%●

Frequently asked

Which is better, BNTX or WST?: It depends on your goal. growth: WST (faster 5Y revenue CAGR); quality: WST (higher ROIC). Across all compared metrics, WST leads 6 to 4.
Which has grown faster, BNTX or WST?: Over the past five years, WST grew revenue faster — BNTX at a 2.16% CAGR versus WST at 6.72%.
Does BNTX or WST pay a bigger dividend?: WST pays a dividend (0.25% yield) while BNTX does not currently pay one.
Is BNTX or WST more profitable?: WST runs the higher net margin — BNTX at -44.73% versus WST at 16.85%.
Which has been the better investment, BNTX or WST?: Over the past 5-year, WST delivered the higher annualized total return — BNTX at -16.66% versus WST at 17.45%. Past performance doesn't predict future results.

Go deeper

Full BNTX analysis Full WST analysis Interactive comparison tool

Dig into the metrics

BioNTech SE P/E ratio West Pharmaceutical Services P/E ratio BioNTech SE dividend yield West Pharmaceutical Services dividend yield BioNTech SE ROE West Pharmaceutical Services ROE BioNTech SE operating margin West Pharmaceutical Services operating margin BioNTech SE revenue growth West Pharmaceutical Services revenue growth BioNTech SE free cash flow West Pharmaceutical Services free cash flow

BioNTech SE & West Pharmaceutical Services appear in these rankings

Dividend Aristocrats Highest FCF Yield Stocks Best 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 27, 2026.